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Background: The objective of this study investigated the distribution of immature dendritic cells (DCs), Langer-
hans cells and plasmacytoid DCs in oral submucous fibrosis (OSMF), OSMF associated with oral squamous cell 
carcinoma (OSMF-OSCC), oral leukoplakia (OL), and oral squamous cell carcinoma (OSCC).
Material and Methods: Fourteen cases of OSMF, 9 of OSMF-OSCC, 8 of OL¸ 45 of OSCC and 8 of normal epi-
thelium were retrospectively retrieved and their diagnoses confirmed. Immunoreactions against CD1a, CD207 e 
CD303 were performed and the number of positive cells quantified.
Results: A significant decrease of CD1a+ was found in OSMF (p≤0.05), OSMF-OSCC (p ≤ 0.01), and OSCC (p 
≤ 0.001) when compared to normal epithelium. For CD207+ the significance decrease was observed in OSMF-
OSCC (p ≤ 0.05), and OSCC (p ≤ 0.01) when compared with normal epithelium, and in OSMF when compared 
with OL (p ≤ 0.05). There was no significant difference for CD303, but increased in CD303+ was observed in 
OSCC when compared with normal epithelium.
Conclusion: The decrease  in  the  number  of  CD1a+  and  CD207+ cells  may be associate to the development of 
oral OSCC, and in OPMDs they might be indicators of malignant transformation.
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Introduction
Oral squamous cell carcinoma (OSCC) accounts for 
more than 90% of all oral malignant neoplasms, repre-
senting the sixth most common malignancy worldwide 
(1). In some Asian countries like Sri Lanka, India, Paki-
stan and Bangladesh, OSCC is even more prevalent (2). 
This variability in the global incidence of OSCC has 
been attributed to cultural habits, including the con-
sumption of tobacco, alcohol, and areca nut. In approxi-
mately one third of the cases, OSCC may arise from oral 
potentially malignant disorders (OPMD), such as oral 
leukoplakia (OL) and oral submucous fibrosis (OSMF).
According to the World Health Organization (WHO), 
OL is defined as a whitish plaque that cannot be charac-
terized clinically or microscopically as any other entity 
(3,4). Tobacco smoking has been observed in 70-90% 
of the patients with OL, (5) and the risk of malignant 
change varies significantly depending on clinical and 
pathological features.
OSMF represents a public health problem, mainly in In-
dia. Previous studies have associated OSMF with use of 
areca nut, which is potentially carcinogenic; however, 
the biological mechanisms involved are not well estab-
lished (6,7). The most common malignant neoplasm 
in South and Southeast Asia is OSMF associated with 
OSCC (OSMF-OSCC) (8,9). OSMF is a fertile soil for 
malignancy and various grades of OSCC do arise in 
background of OSMF (Fig. 1). Moreover, malignancy 
occurs at an accelerated pace in OSMF due to conver-
gence of several pathways and mechanisms (10). Ad-
ditionally, arecoline a component of arecanut has been 
shown to induce genomic instability by producing aber-
rances of mitotic spindle assembly and spindle assembly 
checkpoints (11). It seems that the OSCC arising from 
OSMF and that arising from OL carry widely varying 
prognostic implications, and there is an imperative need 
to study the same.
The immune system has an important role in regulat-
ing OPMD and frankly invasive lesions. Dendritic cells 
(DCs) are antigen-presenting cells responsible for start-
ing the immune response mediated by B and T lym-
phocytes (12). An adequate immune response protects 
the mucosa from malignant transformation (13). The 
distribution of DCs has been studied in several lesions 
for their ability to recognize precursor malignant cells 
and to destroy them. We have previously demonstrated 
a reduction of DC in lip SCC and in actinic cheilitis if 
compared to normal lip mucosa (14), as well as in OSCC 
if compared to normal oral mucosa (13), however, dif-
ference in the distribution of DC between OSCC and 
OSMF-OSCC is unknown. Therefore, in the current 
study we attempted to determine the distribution of im-
mature DCs, Langerhans cells and plasmacytoid DCs 
(pDCs) in OSMF, OSMF-OSCC, OL, and OSCC.
Material and Methods
The study was approved by the ethical commit-
tee of the Piracicaba Dental School (protocol: 
69395817.8.0000.5418). This study includes cases of 
OSMF (n=14) and OSMF-OSCC (n=9) retrieved from 
the files of the Department of Oral Pathology and Mi-
crobiology of the Manipal Academy of Higher Educa-
tion (Manipal, Udupi, Karnataka, India) and another 8 
and 45 cases of OL (all the cases presenting epithelial 
dysplasia) and OSCC from the files of two institutions: 
Piracicaba Dental School, University of Campinas, Bra-
zil; and AC Camargo Cancer Center, São Paulo, Brazil. 
Clinical information such as gender, age and risk fac-
tors was collected from patients’ records. Eight cases 
morphologically normal epithelial tissue adjacent to 
mucoceles were used as control.
Two independent oral pathologists reviewed the original 
5µm histological sections stained with hematoxylin and 
eosin (H&E) of all cases and confirmed the diagnoses. 
Fig. 1: Representative clinical images of patients affected by Oral Submucous Fibrosis (OSMF) and OSMF as-
sociated with oral squamous cell carcinoma (OSMF-OSCC). (A) OSMF clinically demonstrating a whiteness 
and fibrosis of the retromolar area and soft palate. (B) OSMF-OSCC with extensive ulcerative areas.
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Immunohistochemistry was carried out on 3µm sec-
tions of the original formalin-fixed, paraffin-embedded 
tissues. Slides were dewaxed with xylene and rehydrat-
ed in descending ethanol solutions (absolute, 90%, 80% 
and 70%). Antigen retrieval was performed using Tris/
EDTA (pH: 8.0) and the endogenous peroxidase activ-
ity was blocked using 10% hydrogen peroxide. Slides 
were washed in PBS buffer (pH 7.4) and incubated at 
room temperature for 120 min with the antibodies: 
CD207 (Clone EPR15863; Abcam, USA) CD303 (Clone 
124B3.13, 1:50; Dendritics, USA) and CD1a (Clone 010, 
RTU; DAKO Co., USA).
All slides were subsequently exposed to an avidin–bio-
tin complex  containing appropriate secondary antibody 
(Vectastain Elite ABC kit; Vector Laboratories, Burlin-
game, CA, USA). The diaminobenzidine  tetrahydro-
chloride (Sigma, St. Louis, MO, USA) was used for the 
immunochemical reactions according to the manufac-
turer’s instructions; the samples were counterstained 
with Carazzi haematoxylin.
Dendritic cells were manually quantified by one previ-
ously trained observer. Ten sequential fields randomly 
were selected and photographed at 200x magnification 
for positive cell counts. The quantification was per-
formed based on the methodology described by Pelli-
cioli et al. 2017. DCs were quantified in the epithelial 
tissue in the OSMF and OL groups, and in the epithe-
lial infiltrative component and connective tissue from 
OSMF-OSCC and OSCC groups.
The software GraphPad Prism (version 5.0, San Diego, 
California, USA) was used for the statistical analysis. 
Data were submitted to analysis of variance (ANOVA) 
and Tukey tests at a significance level of p < 0.05.
Results
Clinical data are shown in Table 1. Males predominated 
in all lesions. Mean age for the OSCC group (58.5 years) 
was higher than in the OSMF-OSCC group (36.5 years). 
Use of isolated tobacco was reported in cases of OL and 
OSCC groups. 
Table 2 shows the distribution of DCs for all groups. 
We demonstrate a significance reduction for CD1a+ 
and CD207+. DCs were identified as ramified cells in 
normal/neoplastic epithelium and connective tissues 
highlighted by the specific antibodies staining the cell 
membrane.
Fig. 2 and Fig. 3 shows a decrease in the distribution 
of CD1a+ and CD207+ cells in the OSCC group when 
compared with the normal epithelium used as control. 
CD1a+ and CD207+ cells were observed throughout the 
epithelium, while, in the connective tissue, they were 
more prevalent in the tumor nests of the OSMF-OSCC 
and OSCC lesions.
Table 1: Clinical features of control, OL, OSMF, OSFM-OSCC, and 
OSCC groups.
Control Parameter
Mean Age (years) 20.13
n (%)
Gender   
   Male 4 50
   Female 4 50
Site   
   Inferior lip 8 100
OL Parameter
Mean Age (years) 67.88
 n (%)
Gender   
   Male 3 37.5
   Female 5 62.5
Site   
   Buccal mucosa 3 37.5
   Palate 1 12.5
   Tongue 1 12.5
   Others 3 37.5
Isolated Tobacco
   Presence 4 50
   Absence 4 50
OSMF Parameter
Mean Age (years) 28.14
 n (%)
Gender   
   Male 11 91.7
   Female 1 8.3
Site   
   Right buccal mucosa 5 35.7
   Left buccal mucosa 4 28.6
   Bilateral mucosa 5 35.7
OSMF-OSCC Parameter
Mean Age (years) 36.56 
 n (%)
Gender   
   Male 7 77.8
   Female 2 22.2
Site   
   Right buccal mucosa 4 44.4
   Left buccal mucosa 4 44.4
   Bilateral mucosa 1 11.2
OSCC Parameter
Mean Age (years) 58.42 
 n (%)
Gender   
   Male 35 77.8
   Female 10 22.2
Site   
   Floor of the mouth 15 33.4
   Tongue 10 22.2
   Palate 1 2.2
  Others 19 42.2
Isolated Tobacco
   Presence 29 64.4
   Absence 16 35.6
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Fig. 2: Histopathological features and immunohistochemical detection of immature dendritic cells (DCs) and Langerhans 
cells (LCs) of control group (mucocele), oral leukoplakia (OL), oral submucous fibrosis (OSMF), OSMF associated with oral 
squamous cell carcinoma (OSMF-OSCC) and oral squamous cell carcinoma (OSCC). (A) Histologically normal oral epithe-
lium without dysplastic alterations (hematoxylin and eosin – H&E; 200x). (B) Microscopic features of OL (H&E; 200x). (C) 
Microscopic features of OSMF demonstrating submucosal and justaepithelial deposition of collagenated connective tissue 
(H&E; 200x). (D) OSFM-OSCC with infiltrative features and cellular atipia (H&E; 200x). (E) OSCC demonstrating infiltra-
tive tumor nests (H&E; 200x). (F) Immunohistochemical expression of CD1a+ cells in the epithelium tissue of the control 
group (mucocele). (G) OL group. (H) OSMF. (I) OSMF-OSCC. (J) OSCC. (K) CD207+ cells in the control group (mucocele). 
(L) OL group. (M) OSMF. (N)OSMF-OSCC. (O) OSCC. There was a remarkable decrease of CD1a+ and CD207+ cells in 
the OSCC group. (P) CD303+ cells in the control group (mucocele). (Q) OL group. (R) OSMF. (S)OSMF-OSCC. (T) OSCC. 
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A slight increase in the amount of DCs was observed 
in CD303. The concentration of CD303+ cells was 
increased in all groups when compared to the con-
trol group (normal epithelium). The mean of CD303+ 
(Table 2) was 0.13 in the control group, while in the 
other groups were found values such as 0.38 (OL), 0.21 
(OSMF), 2.22 (OSMF-OSCC) and 2.73 (OSCC). How-
ever, no statistical difference was found for CD303 for 
all groups studied.
Table 3 shows the significant decrease in CD1a+ and 
CD207+. We observed which in CD1a was differenc-
es in OSMF (p≤0.05), OSMF- OSCC (p ≤ 0.01), and 
OSCC (p ≤ 0.001) when compared to normal epitheli-
um. For CD207 in OSMF-OSCC (p ≤ 0.05), and OSCC 
(p ≤0.01) when compared to normal epithelium, and this 
reduction was also seen in OSMF when compared with 
OL (p ≤ 0.05).
Discussion
The role of the immune system cells in oral diseases 
have been widely investigated (13-15). Such cells, espe-
cially the DCs, are responsible for recognizing the anti-
gen, processing it, and presenting it to T cells, essential 
steps to regulate the innate and adaptive immunity sys-
tems (16). Our study investigated the distribution profile 
of the DCs in OSMF, OSMF-OSCC, OL, and OSCC and 
revealed a significant decrease of CD1a+ and CD207+ 
cells in oral cancer and OSMF, but not for CD303 posi-
tive cells.
Several DC subtypes are present in the oral mucosa and 
the concentration of these cells may vary according to 
the anatomical topography (17). Our findings show a 
decrease in CD1a+ and CD207+ cells in all the groups 
studied when compared to the normal epithelium, ex-
cept in OL for CD1a+. Supporting this finding, some 
studies have shown which an imbalance in DCs in 
OPMD and frankly invasive lesions can result in less 
activity of the immune response.
Among the markers available for detecting DCs are 
S100, CD1a, CD83, CD207, CD208, CD80, CD11c, 
CD86, CD303 and HLA-DR (16,18). In our study, CD1a, 
Antibody Group Mean and SD p-value 
CD1a
 
ControlA 101.25 ± 58.18 <0.0001
OLA 89.13 ± 67.60
OSMFB 57 ± 42.97
OSMF-OSCCB 40.11 ± 22.44
OSCCC 17 ± 10.86  
CD207
 
ControlA 71.13 ± 47.92 <0.0001
OLAB 75.63 ± 31.60
OSMFA 35.67 ± 25.65
OSMF-OSCCB 26.89 ± 26.15
OSCCC 27.71 ± 29.43  
CD303
 
Control 0.13 ± 0.35 0.0919
OL 0.38 ± 1.06
OSMF 0.21 ± 0.58
OSMF-OSCC 2.22 ± 2.49
OSCC 2.73 ± 4.84  
SD, standard deviation. Different upper-case letters indicate the 
statistical difference comparing each group through the ANOVA 
test with significant level of P<0.05.
Table 2: Quantification of positive cells for all the antibodies in each group.
Fig. 3: Distribution of immature dendritic cells (DCs) (CD1a+), Langerhans cells (CD207+) and plasmacytoid DCs (CD303+) in the 
epithelial compartment of the control group, oral leukoplakia (OL), and oral submucous fibrosis (OSMF), and in the tumor nests of the 
OSMF associated with oral squamous cell carcinoma (OSMF-OSCC) and oral squamous cell carcinoma (OSCC) group. Immature 
DCs were significantly decreased in OSMF, OSMF-OSCC e OSCC when compared to the control group, and LC also were signifi-
cantly decreased in OSMF-OSCC e OSCC when compared to the control group.
CD1a OL OSMF OSMF-OSCC OSCC
Control ns 0.05 0.01 0.001




Control ns ns 0.05 0.01




Table 3: Comparison between all the groups for CD1a and CD207 
antibodies by Tukey analysis. 
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CD207, and CD303 were selected based on previous 
studies investigating different malignant neoplasms and 
the biological behavior of such markers (13,14). CD1a 
and CD207 are effective in identifying immature DCs 
and Langerhans cells. CD303 is used to identify pDCs, 
which are resident in lymphoid or non-lymphoid organs 
and are responsible for the production of type I inter-
feron (19,20).
A decrease in the number of DCs in OL has been as-
sociated with a higher risk of malignant transformation 
(13,16). Additionally, in OL cases DCs decreases occur 
in the presence of smoking habit and increases occur 
in larger lesions and in the presence of dysplasia (21). 
Certainly, our results show higher CD207+ expression 
in OL when compared to controls indicating intact DCs 
function in this stage (Table 2, Fig. 2).
A reduction in the distribution of DCs was observed in 
the OSCC when compared with the OL. Such reduction 
resulted in a decrease in the presentation of antigens, a 
condition that may favor the development and the pro-
gression of OSCC (16). This analysis might allows bet-
ter understand the role of malignant transformation.
CD303+ cells have been associated with organism de-
fense (13). In our study, a gradual increase in CD303+ 
cells was observed for OSMF, OL, OSMF-OSCC, and 
OSCC, respectively, when compared to the control. 
This increase in the CD303+ cells might be related to 
the immune defense mechanism.
The antitumor immune responses may vary according 
to the individuals’ health status (22). It is well estab-
lished that OSMF is associated with the chewing of 
areca nuts; whereas OL is strongly associated with the 
use of isolated tobacco (5,7,23). When compared to non-
smokers, smokers revealed a smaller number of DCs in 
their oral mucosa, a condition that can reduce the indi-
vidual’s immune response (15).
CD207 immunoreactivity was lower in OSMF-OSCC 
than in conventional OSCC, suggesting that arecanut 
might induce a decrease in DCs to a greater extent than 
that induced by isolated tobacco. The expression of the 
CD207 receptor in DCs evidences the antigen is effec-
tively coupled with MHC-I and MHC-II, a condition 
that activates the CD8+ and CD4+ T cells (24); there-
fore, the down-regulation of this receptor in DCs might 
indicate a suppression of the T-cell response. Further 
studies with a greater number of samples and different 
molecular tests are needed to investigate this hypothesis 
and verify our findings.
In conclusion,  the  decrease  in  the  number  of  CD1a+ 
and  CD207+ cells  may be associate to the develop-
ment of OSCC, and in OPMDs they might be indicators 
of malignant transformation. Our preliminary results 
indicate that arecanut chewing may produce a greater 
suppression of immune cell function when compared to 
cigarette smoking alone. Further studies on these cel-
lular alterations are needed for a better understanding 
of the differential malignant transformation of OPMDs 
like OL and OSMF, and their impact on the disease 
pathogenesis and prognosis.
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